Upholding data reliability within drug manufacturing necessitates a robust system to OOS investigations and CAPA plans. Comprehensive reviews of deviations must identify the underlying cause of the issue and promptly trigger a CAPA . Effective corrective actions need to encompass steps to eliminate repetition and demonstrate ongoing betterment. Su